Investigating the function of p95HER2 and the role of pertuzumab and trastuzumab in HER2 cleavage and production of p95HER2 is required to better understand biology of HER2-positive breast cancer and the exact mechanism of action of the anti-HER2 monoclonal antibodies. The gene discussed is ERBB2; the disease is breast carcinoma.